HOME >> BIOLOGY >> NEWS
Evidence suggests that standard smallpox vaccine offers long-term immunity

(Embargoed) CHAPEL HILL - Scientists at the University of North Carolina at Chapel Hill have found evidence indicating that the standard vaccine against smallpox confers long-term immunity.

Writing in the Aug. 29 issue of The New England Journal of Medicine, Dr. Jeffrey A. Frelinger, Kenan professor and chairman of microbiology and immunology in the School of Medicine, and postdoctoral researcher Dr. Lawal Garba said despite substantial interest today "in the durability of immune responses following smallpox vaccination," little direct or quantifiable evidence of such durability exists.

"It's a question that's been largely unexamined," said Frelinger, who mentioned reports suggesting that the standard vaccine, which contains live vaccinia virus but not smallpox, or variola, virus, could protect against lethal infection in people vaccinated 50 years previously.

Vaccinia vaccine triggers an immune response to orthopoxviruses that can infect humans, such as monkeypox, cowpox, vaccinia and variola. During the course of another investigation, Frelinger and Garba tested blood samples from 13 laboratory workers who had been vaccinated according to federal guidelines because they work with vaccinia virus. Four had been vaccinated less than five years ago. Another nine individuals had been vaccinated either between five and 35 years previously or more than 35 years ago.

The researchers tested the strength of each individual's CD8 T cell response to vaccinia exposure by counting the number of cells that respond to vaccinia by production of interferon-gamma.

In the body's cellular immune response, CD8 T cells are a type of cytotoxic T lymphocyte, or CTL, white cells that kill other body cells that have been infected by a foreign organism. CTLs recognize surface markers on other cells in the body that label those cells for destruction. In this way, CTLs help keep virus-infected cells in check. CD8 T cells produce interferon-gamma
'"/>

Contact: Leslie Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
28-Aug-2002


Page: 1 2

Related biology news :

1. Evidence builds for potential new cancer drug target
2. Evidence for sympatric speciation by host shift in the sea
3. Evidence for the impact of climate change on deep-sea biodiversity
4. Evidence for fat hormone target in brain
5. Evidence of nanobacterial-like structures found in human calcified arteries and cardiac valves
6. Evidence shows the heart has stem cells able to regenerate muscle tissue lost to disease, wear
7. Evidence for orangutan culture
8. Evidence that adults stem cells differentiate like embryonic stem cells published in Nature
9. When Shewanella meets goethite: Evidence found of recognition between animate and inanimate objects
10. Evidence links protein damage to Parkinsons
11. Evidence suggests food preservatives may help prevent cavities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... February 11, 2020 , ... ... announce it achieved its ISO 9001:2015 registration by certification body Intertek. Modality Solutions’ ... she reviewed and revised all existing Standard Operating Procedures (SOPs) and created ten ...
(Date:2/10/2020)... , ... February 10, 2020 , ... ... a structural 3D roadmap of the new coronavirus (2019-nCoV), a major development that ... virus. , Using a recently published viral genome of the Wuhan coronavirus made ...
(Date:2/6/2020)... ... 2020 , ... Kerafast Inc. , developers of an ... an agreement with The Good Food Institute , a nonprofit organization committed ... terrestrial meat and aquatic cell lines will be made available to scientists worldwide ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... ... solutions services in North America, today announced that the City of Fort Worth ... its biosolids management needs. Commencing in April of 2020, Synagro will assume operation ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , held ... National Organization for Rare Disorders (NORD), to raise awareness amongst the general public and ... The Balancing Act’s “Behind The Mystery” rare disease series will be shining ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle Biotechnologies ... food and beverage manufactures within North America. Both Lifecycle and Midland have supported ... allow each company to pool their collective resources and provide the industry with ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in ... computing, today announced the availability of neuroscience of transformational leadership workshops. These highly ... neuroscience of leadership and change research to become great transformational leaders. The ...
Breaking Biology Technology:
Cached News: